Dear
Professional,
Greetings for a happy, healthy and progressive New Year!!!
We take the opportunity
to apprise you of the enrolment notification for the Feb’14 batch of Professional
Diploma in Clinical Research (PDCR) and Professional Certificate in
Pharmacovigilance (PCPV) programs. These training programs are aimed at
imparting knowledge and skills required for clinical research and
pharmacovigilance profession. Optimal course fee and ease of training and
evaluation has led to the wider acceptability of the programs amongst students
and researchers.
Highlights of PDCR and PCPV
Programs:
Ease of Training and
Evaluation: Distance learning mode and Assignments based evaluation
Optimal Duration: 6 months
Course Fee: Rs. 9600 each
(DD in favour of Catalyst Clinical Services Pvt. Ltd. payable at Delhi)
Last Date of Enrolment : 10th
February 2014
|
Follow the links
below to download the Application Form. Our placement assistance can also be
viewed on the same link,
Enrollment
Procedure:
In order to enrol, one simply needs to send us the duly filled
Application Form (available at the links above), copy of highest qualification
certificate and DD of prescribed fee to the address mentioned in the footer of
the Application Form.
Advantages of PDCR and PCPV Programs:
-
Increases
the visibility of your CV
-
Equip
you with the required knowledge to handle the potential interview questions
-
Wide
recognition and acceptance of the program(s) throughout the industry
-
Placement
assistance via regular job postings on CR Network
Kindly get in touch if you require any further assistance from our
side.
Thanks and best regards,
Team Catalyst
------------------------------ ------------------------------ ----------------------------
Catalyst Clinical Services Pvt. Ltd.
Corporate office: 503, NDM-2, Netaji Subhash Place,
Pitampura, New Delhi – 110034
Ph: +91-11-45121445; M: +91 9818356273
No comments:
Post a Comment
The Comments are moderated. It will be published only after being by the screened by our team. We request your patience in this regard.